Wearable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Wearable Medical Devices MarketTransparency Market Research is Published new Market Report “Wearable Medical Devices Market (Heart Rate Monitors, Activity Monitors, ECG, Pulse Oximeters, EEG, EMG, Glucose/Insulin Management, Pain Management, Wearable Respiratory Therapy) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019″ The global market for wearable medical devices was valued at USD 2.0 billion in 2012 and is expected to reach a value of USD 5.8 billion in 2019, growing at a CAGR of 16.4% from 2013 to 2019.

Wearable medical devices market defined in the strictest sense are devices with sensors attached to the body that detect and monitor changes in body signatures of various areas and organs. This report focuses on the various segments of wearable devices currently available in the market and also predicts the introduction of several innovative devices in the future. Healthcare segment forms a major part of the wearable technology market since the innovation of several applications in this area in the last two decades.

The meek wrist watch that was used to monitor only heart rate in the last decade has today been transformed into a powerful gadget that can today store vast quantities of data on patient information such as SPO2, heart rate, temperature, blood pressure and water content in the body among several other intelligent diagnostic parameters. Smart phones have made an extremely impressive expansion in terms of applications and can now perform actual diagnostic tests such as the Apple iPhone Glucose test.

The market is highly dynamic and trendy in nature with a heavy importance given to aesthetics and ergonomics of devices. Over 65% of technologies are wrist held devices shaped like watches and the rest include wearability on other areas of the body such as arms, torso and waist. Along with the aesthetics several other features for durability of the device are included such as to make them waterproof and weatherproof. The latest in developments in telecommunication, wireless connectivity and user interface has been applied to these devices to make them more user friendly and keep them easy to interpret even by normal people in order to map their improvement in performance.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/wearable-medical-devices.html

In 2013, Google Inc. introduced the Google Glass, a wearable eyewear that is highly dynamic and has varied applications throughout all industries. The success of the device at a consumer level is yet to be decided, but the technology has proven to be a boon to hospitals and the medical community for telemedicine and teleradiology. Philips has already launched an ambitious project to equip hospitals with the tech along with its proprietary hospital apps and devices in order to gain a better coverage and increase use of its devices. The device can connect into Philips Intellivue Solutions to quickly transfer crucial information of patient vital signs into the glass where it can be stored inside a 16 GB drive for multiple use, transfer it to another doctor, share it over several continents with a specialized medical expert.

Browse full PDF with TOC: Global Wearable Medical Devices Market- Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The market is expected to remain in strong growth phase as purchase power expands for people in emerging countries of Asia-Pacific and Rest of the World. North America remains in lead for 2012 with a market share of 44%. In terms of competition, the market is highly fragmented and there is no clear leader in terms of revenue considering the whole market. Some of the major market players in the global medical sensors market include Nike, Fitbit, Jawbone, Phyode, Basis Science, Corventis, LifeWatch, Intelesens, Philips, Omron, Zephyr Technology Corporation, Polar Electro, Withings, Sotera Wireless and many more companies each with their own innovative technologies. All in all, this report mentions over 100 companies with a brief emphasis on their technologies.

download-pdf

The global wearable medical devices market is categorized into the following segments:

Wearable Medical Devices Market, by Product Types

    • Wearable TherapeuticMedical Devices
    • Wearable DiagnosticMedical Devices

Wearable Diagnostic Medical Devices Market, by Product Types

    • Vital Signs Monitors
    • Fetal & Obstetric Devices
    • Neuromonitoring Devices

Wearable Therapeutic Medical Devices Market, by Product Types

    • Pain Management
    • Glucose/Insulin Monitoring
    • Respiratory Therapy Devices

Wearable Therapeutic Medical Devices Market, by Application

    • Sports and Fitness
    • Remote Patient Monitoring
    • Home Healthcare

Wearable Medical Devices Market, by Geography

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Advertisements

Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

daniel_riconda-genetic_counselor-winnie_palmer_hospital-non_invasive_prenatal_testing-e1362495343686According to a new market report published by Transparency Market Research, “Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global NIPT market was valued at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019, to reach an estimated value of USD 3.62 billion in 2019.

The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers over the conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling (CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a non-invasive genetic screening test for the common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk pregnant women (above the age of 35 years). Owing to its ability to detect the presence of chromosomal abnormalities in fetuses of pregnant women as early as 9 to 10 weeks of gestation, the market for non-invasive prenatal testing market is witnessing a rapid increase in demand from all parts of the world.

MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest are the commercially available NIPTs in the market which are based on the direct analysis of cell-free fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of Sequenom, Inc.) accounted for the largest share (36.6%) of the global NIPT market in terms of revenue, owing to the fact that it was the first mover in the market place. During the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing market penetration by other aforementioned NIPTs such as Panorama and verify.

Browse full PDF with TOC: Non-Invasive Prenatal Testing (NIPT) Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

High incidence rate of babies born with certain type of chromosomal abnormalities, growing trend of child bearing at advanced maternal age and enhanced popularity of NIPT among gynecologists and high risk pregnant women are some of the major factors anticipated to drive growth of the NIPT market during the forecast period. Some of the most commonly detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau syndrome and monosomy X. On the other hand, ethical and regulatory hurdles are expected to pose significant challenges before the NIPT market to grow. Various professional committees across the world believe that the implementation of NIPT and the subsequent rise in uptake of prenatal testing is likely to increase the incidence of abortions. Therefore, professional groups such as The American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics and Gynecology have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.

download-pdf

Geographically, North America was the largest regional market in 2012 with a market share of 64.5% of the total revenue generated globally, followed by Europe. Almost every company operating in this market is adopting the same business model of marketing their tests via alliances with hospitals, diagnostic laboratories and physician offices. The increasing penetration by test developers in European, Asia-Pacific and Middle-East countries indicates promising growth in the near future in these markets. Sequenom, Inc., Verinata Health, Inc. (now a part of Illumina, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Health, LifeCodexx and Berry Genomics are the companies engaged in providing non-invasive prenatal tests worldwide.

The global non-invasive prenatal testing market is segmented as follows:

Non-Invasive Prenatal Testing Market, by Test

  • MaterniT21 PLUS
  • verifi
  • Harmony
  • Panorama
  • NIFTY
  • PrenaTest
  • BambniTest

Non-Invasive Prenatal Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Contact:

Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Browse more market research reports: Transparency Market Research

Hospital Acquired Disease Testing Market Expected to Reach USD 7.5 Billion Globally in 2019: Transparency Market Research

Medical_Devices copyAccording to a new market report published by Transparency Market Research “Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, the global hospital acquired disease testing market was valued at USD 2.2 billionin 2012 and is expected to grow at a CAGR of 19.3% from 2013 to 2019, to reach an estimated value of USD 7.5 billion in 2019.

Browse the full report with TOC: http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

Nosocomial infections/hospital acquired diseases/hospital associated infections (HAI)form one of the critical areas of focus in the healthcare industry. Factors such as increasing prevalence of such conditions in neonatal and geriatric population, initiatives taken up by governments to manage nosocomial infections, increasing number of diseases that increases risk of hospital associated infections, and growing concerns about control and prevention of nosocomial infections worldwide will have a positive impact on the current hospital acquired disease testing industry.

The global hospital acquired disease testing market is segmented on the basis of type of infection and geography. Based on the different typesof infection,this market is classified into pneumonia, urinary tract infection, blood stream infection, surgical site associated infection, MRSA infection testing and others. The hospital acquired urinary tract infection diagnostics segment occupies the largest market share in this category as prevalence and morbidity rate of this condition, and the demand for diagnostic solutions for the same is the highest as compared to other hospital associated infections. It is expected that the global market for hospital associated urinary tract infection testing will reach USD 2,188.8 million in 2019 with the market growing at CAGR of 18.1%from 2013 to 2019. Furthermore, other testing solutions for conditions such as surgical site infections and pneumonia (hospital associated and ventilator associated infections) will also experience high demand in lesser developed regions of Asia-Pacific, Latin America and other developing countries where the prevalence of such conditions is higher. It is expected that the market for surgical site infections will grow at a CAGR of 20.1%during the given period of forecast.

Geographically, United States and Canada together are the leaders in the global hospital acquired disease testing market with a combined market share (of the North American region) of 41.3% in 2012. Some of the major growth drivers for the North American nosocomial infection testing market include existence of highly developed healthcare infrastructure, high rate of implementation of healthcare guidelines given by regulatory and guiding institutions such as Centers for Disease Control and Prevention (U.S.), and increasing awareness about these diseases and their prevention. The European Union considers infectious diseases as an increasing threat to the general public health; the public health system in this region is increasingly engaging itself in conducting dialogue between healthcare providers and medical practitioners for developing better, faster and cost effective methods for nosocomial infection management and prevention. Asian countries including China, Philippines and India are the most potential markets for such diagnostic and testing solutions owing to existence of factors such as higher population, poor hospital infrastructure, lack of adherence to sanitation procedures and therefor higher disease prevalence growth rates. UAE and African countries are some of the lucrative markets in the Rest of the World (RoW).

Browse full PDF with TOC: Hospital Acquired Disease Testing Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Molecular diagnostics solutions play a vital role in this market as they offer precise, faster and cost effective diagnosis for various nosocomial infections. Considering the market competition, the global hospital acquired infection testing market is highly fragmented and is characterized by the existence of several large and mid-sized diagnostic solution providers. Some of the key market players contributing to this industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc.,Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

The global hospital acquired disease testing market is segmented as follows:

Hospital Acquired Disease Testing Market, by Infection Type

  • Pneumonia infection
  • Urinary tract infection
  • Blood stream associated infection
  • Surgical site infection
  • MRSA infection

Hospital Acquired Disease Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World